227 results on '"Momeni-Boroujeni, Amir"'
Search Results
2. Evolutionary pathways in early-stage, non-myoinvasive endometrioid endometrial cancers of no specific molecular profile
3. Lymph node metastases in endometrial carcinoma: A modern assessment in the era of sentinel lymph node mapping and molecular subtyping
4. Concurrent POLE hotspot mutations and mismatch repair deficiency/microsatellite instability in endometrial cancer: A challenge in molecular classification
5. POLE-Mutated Uterine Carcinosarcomas: A Clinicopathologic and Molecular Study of 11 Cases
6. Expanding the Spectrum of NR4A3 Fusion–Positive Gynecologic Leiomyosarcomas
7. TERT promoter mutations and gene amplification in endometrial cancer
8. The Significance of International Federation of Gynecology and Obstetrics Grading in Microsatellite Instability-High and POLE-Mutant Endometrioid Endometrial Carcinoma
9. Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma
10. Incidence and Clinicopathologic Characteristics of Human Papillomavirus–independent Invasive Squamous Cell Carcinomas of the Cervix: A Morphologic, Immunohistochemical, and Human Papilloma-Virologic Study of 670 Cases
11. Landscape of chromatin remodeling gene alterations in endometrial carcinoma
12. Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis
13. Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors
14. Genomic landscape of endometrial carcinomas of no specific molecular profile
15. ERBB2 amplification status in 67 salivary duct carcinomas assessed by immunohistochemistry, fluorescence in situ hybridization, and targeted exome sequencing
16. Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma
17. TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition
18. Risk Stratification of Uterine Smooth Muscle Tumors: The Role of Morphology, Immunohistochemistry, and Molecular Testing
19. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma
20. Rapid EGFR Mutation Detection Using the Idylla Platform: Single-Institution Experience of 1200 Cases Analyzed by an In-House Developed Pipeline and Comparison with Concurrent Next-Generation Sequencing Results
21. A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing
22. Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma
23. Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas
24. DNA methylation-based classification of sinonasal undifferentiated carcinoma
25. Digital Droplet PCR Based Monitoring of CAR-T Cell Expansion in Lymphoma Patients: Impact on Treatment Outcome
26. Detection of CAR-T Cell Persistence with Digital Droplet PCR: Correlation of In Vivo Expansion with Clinical Outcomes in a Cohort of B-Cell Lymphoma Patients
27. Decreased HER2 expression in endometrial cancer following anti‐HER2 therapy
28. Supplementary Table S3 from Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets
29. Supplementary Figure S3 from Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets
30. Data from Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets
31. Data from Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications
32. PR046/#280 The genomic landscape of distant metastatic endometrial cancer
33. PR032/#594 Refining copy number-low endometrial carcinoma by estrogen receptor immunohistochemistry
34. Supplementary Figures S1-S6 from Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications
35. Validation of a High-Sensitivity Assay for Detection of Chimeric Antigen Receptor T-Cell Vectors Using Low-Partition Digital PCR Technology
36. Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications
37. Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets
38. Systematic Error Detection in Laboratory Medicine
39. Decreased HER2 expression in endometrial cancer following anti‐HER2 therapy.
40. Figure S1 from Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell Tumor
41. Supplementary Data from Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas
42. O015/#502 Molecular stratification of ovarian clear cell carcinoma predicts clinical outcomes
43. Computer‐assisted cytologic diagnosis in pancreatic FNA: An application of neural networks to image analysis
44. High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer
45. Using patient biomarker time series to determine mortality risk in hospitalised COVID-19 patients: A comparative analysis across two New York hospitals
46. Evaluation of TERT mRNA expression using RNAscope®: A potential histopathologic diagnostic and prognostic tool
47. Outcome-based Validation of Confluent/Expansile Versus Infiltrative Pattern Assessment and Growth-based Grading in Ovarian Mucinous Carcinoma
48. Using patient biomarker time series to determine mortality risk in hospitalised COVID-19 patients: a comparative analysis across two New York hospitals
49. Somatic intronicTP53c.375+ 5G mutations are a recurrent but under‐recognized mode ofTP53inactivation
50. A Dynamic Bayesian Model for Identifying High-Mortality Risk in Hospitalized COVID-19 Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.